Elkton, MD, United States of America

Frank E Klein

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Elkton, MD (US) (1995)
  • Eklton, MD (US) (1996)

Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frank E Klein: Innovator in Pharmaceutical Chemistry

Introduction

Frank E Klein is a notable inventor based in Elkton, MD (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel derivatives of procainamide and N-acetylprocainamide (NAPA). With a total of 2 patents to his name, Klein's inventions have the potential to impact medical treatments significantly.

Latest Patents

Klein's latest patents include "Piperidine analogs and conjugates of procainamide and NAPA." This patent discloses novel derivatives of procainamide and N-acetylprocainamide (NAPA) characterized by a specific formula. Another significant patent is "Maleimide adduct conjugates of procainamide and NAPA," which also presents novel derivatives of procainamide and N-acetylprocainamide (NAPA) with a similar formula. These innovations highlight Klein's expertise in developing new pharmaceutical compounds.

Career Highlights

Frank E Klein is currently associated with Boehringer Mannheim GmbH, where he continues to advance his research in pharmaceutical chemistry. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Klein's notable coworkers include Gerald F Sigler and Charles F Walter. Their collaborative efforts contribute to the innovative environment at Boehringer Mannheim GmbH.

Conclusion

Frank E Klein's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to innovation in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…